Home
About
Overview
Sharing Data
ORCID
Help
History (2)
Incorporating preemptive pharmacogenomic testing into the clinical setting.
Perspective and priorities for improvement of parathyroid hormone (PTH) measurement - A view from the IFCC Working Group for PTH.
See All 2 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Incorporating preemptive pharmacogenomic testing into the clinical setting.
Incorporating preemptive pharmacogenomic testing into the clinical setting. Clin Adv Hematol Oncol. 2020 09; 18(9):526-529.
View in:
PubMed
subject areas
Humans
Pharmacogenetics
Pharmacogenomic Testing
Precision Medicine
authors with profiles
Peter O'Donnell